|
DE3508258A1
(de)
|
1985-03-08 |
1986-09-18 |
Bayer Ag, 5090 Leverkusen |
Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
|
|
FR2643903A1
(fr)
|
1989-03-03 |
1990-09-07 |
Union Pharma Scient Appl |
Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
|
|
DE4023369A1
(de)
|
1990-07-23 |
1992-01-30 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
|
US5614519A
(en)
|
1991-02-06 |
1997-03-25 |
Karl Thomae Gmbh |
(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
|
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
|
DE4225756A1
(de)
|
1992-01-22 |
1994-03-10 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4224752A1
(de)
|
1992-04-11 |
1994-02-03 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5125961A
(en)
|
1991-08-12 |
1992-06-30 |
Monsanto Company |
Substituted pyridine compounds
|
|
DE4219534A1
(de)
|
1992-02-19 |
1993-12-16 |
Thomae Gmbh Dr K |
Substituierte Biphenylylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4408497A1
(de)
|
1994-03-14 |
1995-09-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
JPH10503768A
(ja)
|
1994-08-02 |
1998-04-07 |
メルク シヤープ エンド ドーム リミテツド |
アゼチジン、ピロリジンおよびピペリジン誘導体
|
|
CN1072669C
(zh)
|
1995-04-21 |
2001-10-10 |
纽罗研究公司 |
苯并咪唑化合物及其用作gabaa受体复合物调节器的用途
|
|
JP2000072675A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
AU760250B2
(en)
|
1998-12-04 |
2003-05-08 |
Neurosearch A/S |
New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
|
|
US6380235B1
(en)
|
1999-05-04 |
2002-04-30 |
American Home Products Corporation |
Benzimidazolones and analogues
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
|
EP1263754A1
(en)
|
2000-02-01 |
2002-12-11 |
Millennium Pharmaceuticals, Inc. |
INDALONE AND BENZIMIDAZOLONE INHIBITORS OF FACTOR Xa
|
|
US20120028912A1
(en)
|
2000-02-22 |
2012-02-02 |
J.David Gladstone Institute |
Methods of modulating bromodomains
|
|
MXPA03004672A
(es)
|
2000-10-27 |
2004-04-20 |
Dow Agrosciences Llc |
4,5-dihidro-1,2,4-triazin-6-onas sustituidas, 1,2,4-triazin-6-onas sustituidas, y su uso como fungicidas e insecticidas.
|
|
EA007254B1
(ru)
|
2000-12-01 |
2006-08-25 |
Оси Фармасьютикалз, Инк. |
Соединения, специфические к аденозиновому а, аи арецептору, и их применение
|
|
WO2002070486A1
(en)
|
2001-03-01 |
2002-09-12 |
Shionogi & Co., Ltd. |
Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
|
|
CA2440211A1
(en)
|
2001-03-09 |
2002-09-19 |
Pfizer Products Inc. |
Benzimidazole anti-inflammatory compounds
|
|
DE60221368T2
(de)
|
2001-03-15 |
2008-04-17 |
Janssen Pharmaceutica N.V. |
Hiv hemmende pyrazinon-derivate
|
|
MXPA03008658A
(es)
|
2001-03-23 |
2005-04-11 |
Bayer Ag |
Inhibidores de rho-cinasa.
|
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
EP1381598A4
(en)
|
2001-03-28 |
2008-03-19 |
Bristol Myers Squibb Co |
NEW INHIBITORS OF TYROSINE KINASE
|
|
US20050176858A1
(en)
|
2002-02-15 |
2005-08-11 |
Bridgestone Corporation |
Rubber composition and pneumatic tire made therefrom
|
|
TWI276631B
(en)
|
2002-09-12 |
2007-03-21 |
Avanir Pharmaceuticals |
Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
|
|
US20040166137A1
(en)
|
2002-11-08 |
2004-08-26 |
Lackey John William |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
AR043063A1
(es)
|
2002-12-13 |
2005-07-13 |
Altana Pharma Ag |
Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
|
|
AR042956A1
(es)
|
2003-01-31 |
2005-07-13 |
Vertex Pharma |
Inhibidores de girasa y usos de los mismos
|
|
CL2004000409A1
(es)
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
|
WO2004098494A2
(en)
|
2003-04-30 |
2004-11-18 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
AU2003902860A0
(en)
|
2003-06-06 |
2003-06-26 |
Daicel Chemical Industries, Ltd |
Benzimidazole compounds
|
|
US20050256179A1
(en)
|
2003-08-08 |
2005-11-17 |
Sircar Jagadish C |
Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
|
|
CL2004002050A1
(es)
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
WO2005080380A1
(en)
|
2004-02-03 |
2005-09-01 |
Eli Lilly And Company |
Kinase inhibitors
|
|
WO2005075432A1
(ja)
|
2004-02-06 |
2005-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
１−（２ｈ）−イソキノロン誘導体およびその抗ガン剤としての使用
|
|
CA2559552A1
(en)
|
2004-03-23 |
2005-09-29 |
F. Hoffmann-La Roche Ag |
Benzyl-pyridazinone derivatives as non-nucleoside reverse transcriptase inhibitors
|
|
US20080015196A1
(en)
|
2004-04-16 |
2008-01-17 |
Neurogen Corporation |
Imidazopyrazines, Imidazopyridines, and Imidazopyrimidines as Crf1 Receptor Ligands
|
|
KR101258298B1
(ko)
|
2004-06-01 |
2013-04-25 |
유니버시티 오브 버지니아 페이턴트 파운데이션 |
암 및 혈관형성의 이중 소분자 억제제
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
MX2007001986A
(es)
|
2004-08-26 |
2007-05-10 |
Pfizer |
Compuestos de aminoheteroarilo como inhibidores de proteina quinasa.
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038734A1
(en)
*
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
CA2584485C
(en)
|
2004-10-20 |
2013-12-31 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
DK1848718T3
(da)
|
2005-02-04 |
2012-08-27 |
Millennium Pharm Inc |
E1 aktiveringsenzymhæmmere
|
|
US7893267B2
(en)
|
2005-03-14 |
2011-02-22 |
High Point Pharmaceuticals, Llc |
Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
|
|
WO2006119400A2
(en)
|
2005-05-03 |
2006-11-09 |
Dow Agrosciences Llc |
Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
|
|
CN101365446B
(zh)
|
2005-07-29 |
2013-05-22 |
雷斯弗洛吉克斯公司 |
预防和治疗复杂疾病的药物组合物及其经由可植入医药装置的递送
|
|
CA2623813A1
(en)
|
2005-10-03 |
2007-04-12 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
|
|
WO2007061923A2
(en)
|
2005-11-18 |
2007-05-31 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
PL1959951T3
(pl)
|
2005-12-01 |
2010-06-30 |
Hoffmann La Roche |
Heteroarylo-podstawione pochodne piperydyny jako inhibitory l-cpt1
|
|
AU2007216247A1
(en)
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as TLR7 modulators
|
|
CN101384593A
(zh)
|
2006-02-17 |
2009-03-11 |
辉瑞有限公司 |
用作tlr7调节剂的3-脱氮嘌呤衍生物
|
|
BRPI0709366B8
(pt)
|
2006-03-24 |
2018-05-29 |
Oreal |
colorante fluorescente tiol, composições de tintura, processo de coloração de matérias queratínicas, dispositivo e uso dos corantes fluorescentes
|
|
BRPI0709660A2
(pt)
|
2006-04-03 |
2011-07-19 |
Glaxo Group Limided |
derivados de azabiciclo [3,1,0] hexila como moduladores dos receptores de dopamina d3
|
|
CA2700988A1
(en)
|
2006-09-27 |
2008-05-08 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
EP2121621B1
(en)
*
|
2006-12-08 |
2014-05-07 |
Exelixis Patent Company LLC |
Lxr and fxr modulators
|
|
PL2094662T3
(pl)
|
2006-12-14 |
2012-09-28 |
Astellas Pharma Inc |
Związki oparte na policyklicznych kwasach użyteczne jako antagoniści rCRTH2 oraz jako środki przeciwalergiczne
|
|
SG144809A1
(en)
|
2007-01-11 |
2008-08-28 |
Millipore U K Ltd |
Benzimidazole compounds and their use as chromatographic ligands
|
|
DK2118074T3
(en)
|
2007-02-01 |
2014-03-10 |
Resverlogix Corp |
Compounds for the prevention and treatment of cardiovascular diseases
|
|
WO2008153701A1
(en)
|
2007-05-24 |
2008-12-18 |
Schering Corporation |
Compounds for inhibiting ksp kinesin activity
|
|
JP5492770B2
(ja)
|
2007-06-26 |
2014-05-14 |
サノフイ |
ベンゾイミダゾール及びアザベンゾイミダゾールの位置選択的銅触媒合成
|
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102007038957A1
(de)
|
2007-08-17 |
2009-02-19 |
Merck Patent Gmbh |
6-Thioxo-pyridazinderivate
|
|
GB0719235D0
(en)
|
2007-10-02 |
2007-11-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2009054790A1
(en)
|
2007-10-26 |
2009-04-30 |
Astrazeneca Ab |
Amide linked heteroaromatic derivatives as modulators of mglur5
|
|
WO2009079001A1
(en)
|
2007-12-18 |
2009-06-25 |
Janssen Pharmaceutica N.V. |
Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine h4 receptor
|
|
CN101910182B
(zh)
|
2007-12-28 |
2013-07-17 |
田边三菱制药株式会社 |
抗癌剂
|
|
TW200938542A
(en)
|
2008-02-01 |
2009-09-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
WO2009158258A1
(en)
|
2008-06-25 |
2009-12-30 |
E. I. Du Pont De Nemours And Company |
Herbicidal dihydro oxo six-membered azinyl isoxazolines
|
|
US20100012745A1
(en)
|
2008-07-15 |
2010-01-21 |
Sturman Digital Systems, Llc |
Fuel Injectors with Intensified Fuel Storage and Methods of Operating an Engine Therewith
|
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
JP2012500260A
(ja)
|
2008-08-18 |
2012-01-05 |
イェール・ユニヴァーシティー |
Ｍｉｆモジュレーター
|
|
EP2379561B1
(en)
|
2008-11-25 |
2015-11-04 |
University Of Rochester |
Mlk inhibitors and methods of use
|
|
US8940891B2
(en)
|
2008-12-08 |
2015-01-27 |
Arena Pharmaceuticals, Inc. |
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
DE102008062826A1
(de)
|
2008-12-23 |
2010-07-01 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
US8389550B2
(en)
|
2009-02-25 |
2013-03-05 |
Hoffmann-La Roche Inc. |
Isoxazoles / O-pyridines with ethyl and ethenyl linker
|
|
JP2012519732A
(ja)
|
2009-03-09 |
2012-08-30 |
サーフェイス ロジックス，インコーポレイティド |
Ｒｈｏキナーゼ阻害剤
|
|
EP2408449A4
(en)
|
2009-03-18 |
2012-08-08 |
Univ Leland Stanford Junior |
METHOD AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE VIRUS INFECTIONS
|
|
CN105859639A
(zh)
|
2009-03-18 |
2016-08-17 |
雷斯韦洛吉克斯公司 |
新的抗炎剂
|
|
CN107252429B
(zh)
|
2009-04-22 |
2023-06-16 |
雷斯韦洛吉克斯公司 |
新抗炎剂
|
|
JP5466292B2
(ja)
|
2009-05-05 |
2014-04-09 |
エフ．ホフマン−ラ ロシュ アーゲー |
イソオキサゾール−ピリジン誘導体
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
ES2652304T3
(es)
|
2009-11-05 |
2018-02-01 |
Glaxosmithkline Llc |
Compuesto de benzodiacepina novedoso
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
EP3050885B1
(en)
|
2009-11-05 |
2017-10-18 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
US9034850B2
(en)
|
2009-11-20 |
2015-05-19 |
Sk Chemicals Co., Ltd. |
Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same
|
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
|
KR101165996B1
(ko)
|
2010-04-23 |
2012-07-18 |
주식회사 녹십자 |
프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
HUE031073T2
(en)
|
2010-05-14 |
2017-06-28 |
Dana Farber Cancer Inst Inc |
Thieno triazolo-diazepine compounds for the treatment of neoplasia
|
|
CA2810162A1
(en)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
WO2011159926A1
(en)
|
2010-06-16 |
2011-12-22 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
CA2803448A1
(en)
|
2010-07-06 |
2012-01-12 |
Universite De Montreal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
|
US8993779B2
(en)
|
2010-08-12 |
2015-03-31 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of MGLUR2
|
|
WO2012040499A2
(en)
|
2010-09-22 |
2012-03-29 |
Surface Logix, Inc. |
Metabolic inhibitors
|
|
KR101242572B1
(ko)
|
2010-10-12 |
2013-03-19 |
한국화학연구원 |
5-환 헤테로 아릴로 치환된 프탈라지논 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
|
CN102731409A
(zh)
|
2011-04-08 |
2012-10-17 |
中国科学院上海药物研究所 |
一类哒嗪酮类化合物，其药物组合物、制备方法及用途
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2721031B1
(en)
|
2011-06-17 |
2016-01-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
JP5992049B2
(ja)
|
2011-11-01 |
2016-09-14 |
レスバーロジックス コーポレイション |
置換されたキナゾリノンのための経口速放性製剤
|
|
JP6141863B2
(ja)
|
2011-12-01 |
2017-06-07 |
ケモセントリックス，インコーポレイティド |
Ｃｃｒ（４）アンタゴニストとしての置換ベンズイミダゾール及びベンゾピラゾール
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
US20130281396A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281398A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
HK1206744A1
(en)
|
2012-04-20 |
2016-01-15 |
Abbvie Inc. |
Isoindolone derivatives
|
|
EP2864336B1
(en)
|
2012-06-06 |
2016-11-23 |
Constellation Pharmaceuticals, Inc. |
Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
CN104428293B
(zh)
|
2012-06-11 |
2018-06-08 |
Ucb生物制药私人有限公司 |
调节TNFα的苯并咪唑类
|
|
EP2888256A4
(en)
|
2012-08-24 |
2016-02-17 |
Univ Texas |
HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES
|
|
CN104780764A
(zh)
|
2012-09-05 |
2015-07-15 |
拜尔农作物科学股份公司 |
取代的2-酰氨基苯并咪唑、2-酰氨基苯并噁唑和2-酰氨基苯并噻唑或其盐作为活性物质对抗非生物植物胁迫的用途
|
|
US20150246888A1
(en)
|
2012-09-11 |
2015-09-03 |
Michael Johnson |
Enoyl reductase inhibitors with antibacterial activity
|
|
EP2920183B1
(en)
|
2012-11-14 |
2017-03-08 |
Glaxosmithkline LLC |
Thieno[3,2-c]pyridin-4(5h)-ones as bet inhibitors
|
|
WO2014080290A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Cyclic amines as bromodomain inhibitors
|
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
|
WO2014095775A1
(de)
|
2012-12-20 |
2014-06-26 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische dihydrochinoxalinone
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
HK1212345A1
(en)
|
2013-02-22 |
2016-06-10 |
Bayer Pharma Aktiengesellschaft |
4-substituted pyrrolo- and pyrazolo-diazepines
|
|
WO2014128070A1
(de)
|
2013-02-22 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo- und pyrazolo-triazolodiazepine als bet-proteininhibitoren zur behandlung von hyper-proliferativen erkrankungen
|
|
WO2014128655A1
(en)
|
2013-02-25 |
2014-08-28 |
Aurigene Discovery Technologies Limited |
Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
|
|
US9492460B2
(en)
|
2013-02-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
CN105189488B
(zh)
|
2013-02-27 |
2018-07-24 |
百时美施贵宝公司 |
用作溴区结构域抑制剂的咔唑化合物
|
|
CN105377851B
(zh)
|
2013-03-11 |
2018-07-20 |
密执安州立大学董事会 |
Bet布罗莫结构域抑制剂和使用这些抑制剂的治疗方法
|
|
CA2904048A1
(en)
|
2013-03-11 |
2014-10-09 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
BR112015022674A2
(pt)
|
2013-03-11 |
2017-07-18 |
Abbvie Inc |
inibidores de bromodomínio
|
|
US9493411B2
(en)
|
2013-03-12 |
2016-11-15 |
Abbvie Inc. |
Pyrrole-3-carboxamide bromodomain inhibitors
|
|
KR20150126696A
(ko)
|
2013-03-12 |
2015-11-12 |
애브비 인코포레이티드 |
디하이드로-피롤로피리디논 브로모도메인 억제제
|
|
BR112015022417A2
(pt)
|
2013-03-14 |
2017-07-18 |
Convergene Llc |
métodos e composições para inibição de proteínas contendo bromodomínio
|
|
ES2704048T3
(es)
|
2013-03-14 |
2019-03-14 |
Glaxosmithkline Ip No 2 Ltd |
Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina-2,3-disustituida y su uso como inhibidores de bromodominio
|
|
WO2014140077A1
(en)
|
2013-03-14 |
2014-09-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Furopyridines as bromodomain inhibitors
|
|
US20160039842A1
(en)
|
2013-03-15 |
2016-02-11 |
Epigenetix, Inc. |
Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
|
|
RU2680100C9
(ru)
|
2013-03-15 |
2019-04-18 |
Плексксикон Инк. |
Гетероциклические соединения и их применения
|
|
TWI719464B
(zh)
|
2013-03-15 |
2021-02-21 |
美商英塞特控股公司 |
作為bet蛋白抑制劑之三環雜環
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
JP6370368B2
(ja)
|
2013-03-27 |
2018-08-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｒｄ４阻害剤としてのインドリノン類似体
|
|
US9199988B2
(en)
|
2013-03-27 |
2015-12-01 |
Boehringer Ingelheim International Gmbh |
Dihydroquinazolinone analogues
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
US10435364B2
(en)
|
2013-04-17 |
2019-10-08 |
Albert Ludwigs Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EP2792355A1
(en)
|
2013-04-17 |
2014-10-22 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
WO2014173241A1
(en)
|
2013-04-26 |
2014-10-30 |
Beigene, Ltd. |
Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
MX2015016344A
(es)
|
2013-05-27 |
2016-03-01 |
Novartis Ag |
Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
|
|
US8975417B2
(en)
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
CA2915419A1
(en)
|
2013-06-17 |
2014-12-24 |
Bayer Pharma Aktiengesellschaft |
Substituted phenyl-2,3-benzodiazepines
|
|
ES2661437T3
(es)
|
2013-06-21 |
2018-04-02 |
Zenith Epigenetics Corp. |
Nuevos compuestos bicíclicos sustituidos como inhibidores de bromodominio
|
|
SI3010503T1
(sl)
|
2013-06-21 |
2020-07-31 |
Zenith Epigenetics Ltd. |
Novi biciklični inhibitorji bromodomene
|
|
AR096758A1
(es)
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
JP2016523964A
(ja)
|
2013-07-08 |
2016-08-12 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｂｅｔタンパク質阻害剤としての三環式複素環
|
|
WO2015011084A1
(de)
|
2013-07-23 |
2015-01-29 |
Bayer Pharma Aktiengesellschaft |
Substituierte dihydropyrido[3,4-b]pyrazinone als duale inhibitoren von bet-proteinen und polo-like kinasen
|
|
KR20160034379A
(ko)
|
2013-07-25 |
2016-03-29 |
다나-파버 캔서 인스티튜트 인크. |
전사 인자의 억제제 및 그의 용도
|
|
CN105593224B
(zh)
|
2013-07-31 |
2021-05-25 |
恒元生物医药科技(苏州)有限公司 |
作为溴结构域抑制剂的新型喹唑啉酮类化合物
|
|
US20150051208A1
(en)
|
2013-08-14 |
2015-02-19 |
Boehringer Ingelheim International Gmbh |
Pyridinones
|
|
DK3071203T3
(da)
|
2013-11-18 |
2021-03-15 |
Forma Therapeutics Inc |
Tetrahydroquinolinsammensætninger som bet-bromdomæne-inhibitorer
|
|
RU2720237C2
(ru)
|
2013-11-18 |
2020-04-28 |
Форма Терапеутикс, Инк. |
Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
|
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
US9458156B2
(en)
|
2014-12-23 |
2016-10-04 |
Bristol-Myers Squibb Company |
Tricyclic compounds as anticancer agents
|
|
EP3227280B1
(en)
|
2014-12-01 |
2019-04-24 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
US10710992B2
(en)
|
2014-12-01 |
2020-07-14 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
US10292968B2
(en)
|
2014-12-11 |
2019-05-21 |
Zenith Epigenetics Ltd. |
Substituted heterocycles as bromodomain inhibitors
|
|
CA2966450A1
(en)
|
2014-12-17 |
2016-06-23 |
Olesya KHARENKO |
Inhibitors of bromodomains
|
|
CA2966452A1
(en)
|
2014-12-17 |
2016-06-23 |
Samuel David Brown |
Substituted bicyclic compounds as bromodomain inhibitors
|
|
CA2915661A1
(en)
|
2014-12-23 |
2016-06-23 |
Husky Oil Operations Limited |
Multilateral well completions to improve individual branch control
|